Efficacy of delayed administration of sargramostim up to 120 hours post exposure in a nonhuman primate total body radiation model.
CONCLUSION: In a NHP ARS model, sargramostim administered starting at 48 h post-radiation was effective to improve survival, while beneficial hematological effects were observed with sargramostim initiated up to 120 h post exposure.
PMID: 32960660 [PubMed - as supplied by publisher]
Source: International Journal of Radiation Biology - Category: Radiology Tags: Int J Radiat Biol Source Type: research
More News: Azithromycin | Biology | Depression | Hematology | Pancytopenia | Radiology | Study | Zithromax